Explore our materials

Filters

Results (5583)

Slideset

HIV

INTEREST 2016

(Abstract) Retention in care among HIV-infected pregnant mothers on lifelong antiretroviral therapy (art) in Uganda | S. Muhumuza

Slideset

HIV

INTEREST 2016

(Abstract) Getting pregnant in antiretroviral clinical trials: women choice and safety needs. Experience from the ANRS12169-2LADY and ANRS12286- MOBIDIP trials | A. Serris

Slideset

HIV

INTEREST 2016

(Abstract) Maximizing EID opportunities using the DBS Mentor Approach in Rural HIV Clinics in South-Eastern Nigeria | P. Anyanwu

Slideset

HIV

INTEREST 2016

(Abstract) Model-based pediatric dosing of ritonavir-boosted Darunavir: an alternative to WHO guidelines | P. Mohammed

Slideset

HIV

INTEREST 2016

(Abstract) Quality of life among HIV/AIDS patients on anti retro-viral therapy at Letlhakane primary hospital (Botswana): a cross sectional study | L. Kumboneki

Slideset

HIV

INTEREST 2016

(Abstract) Current profile of dermatological diseases and events during HIV in Dakar | N.M.Dia

Slideset

HIV

INTEREST 2016

(Abstract) Prevalence of non-infectious co-morbidities among HIV-positive subjects stably treated with tenofovir, lamivudine and ritonavir-boosted lopinavir in Cameroon | D. Fokom Victoire

Slideset

HIV

INTEREST 2016

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Isaac Tita

Slideset

HIV

INTEREST 2016

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Opposing the motion | Badara Samb, MD, PhD

Slideset

HIV

INTEREST 2016

(Abstract) Ultra-deep pyrosequencing of paediatric HIV-1 drug resistance and coreceptor suggests possible suitability of protease inhibitors and maraviroc at younger ages in Cameroon | J. Fokam

Mauro Schechter

MD, PhD

Slideset

HIV

INTEREST 2016

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Mauro Schechter, MD, PhD

Victor Musiime

MBChB, MMed, PhD

Slideset

HIV

INTEREST 2016

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

(Abstract) Retention in care among HIV-infected pregnant mothers on lifelong antiretroviral therapy (art) in Uganda | S. Muhumuza

(Abstract) Getting pregnant in antiretroviral clinical trials: women choice and safety needs. Experience from the ANRS12169-2LADY and ANRS12286- MOBIDIP trials | A. Serris

(Abstract) Maximizing EID opportunities using the DBS Mentor Approach in Rural HIV Clinics in South-Eastern Nigeria | P. Anyanwu

(Abstract) Model-based pediatric dosing of ritonavir-boosted Darunavir: an alternative to WHO guidelines | P. Mohammed

(Abstract) Quality of life among HIV/AIDS patients on anti retro-viral therapy at Letlhakane primary hospital (Botswana): a cross sectional study | L. Kumboneki

(Abstract) Current profile of dermatological diseases and events during HIV in Dakar | N.M.Dia

(Abstract) Prevalence of non-infectious co-morbidities among HIV-positive subjects stably treated with tenofovir, lamivudine and ritonavir-boosted lopinavir in Cameroon | D. Fokom Victoire

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Isaac Tita

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Opposing the motion | Badara Samb, MD, PhD

(Abstract) Ultra-deep pyrosequencing of paediatric HIV-1 drug resistance and coreceptor suggests possible suitability of protease inhibitors and maraviroc at younger ages in Cameroon | J. Fokam

Formal Debate: Resolved that 90-90-90 Cannot be Attained | Affirming the motion | Mauro Schechter, MD, PhD

90-90-90 for all - Scale up of HIV Treatment for Adolescents | Victor Musiime, MBChB, MMED, PhD